Kappac Pharma Profile
Key Indicators
- Authorised Capital ₹ 24.00 Cr
as on 18-12-2024
- Paid Up Capital ₹ 30.27 Cr
as on 18-12-2024
- Company Age 43 Year, 4 Months
- Last Filing with ROC 31 Mar 2015
- Open Charges ₹ 1.68 Cr
as on 18-12-2024
- Revenue %
(FY 2015)
- Profit 5.47%
(FY 2015)
- Ebitda -60.45%
(FY 2015)
- Net Worth -0.21%
(FY 2015)
- Total Assets -1.46%
(FY 2015)
About Kappac Pharma
The Corporate was formerly known as Kappac Pharma Private Ltd. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2015. It's a company limited by shares with an authorized capital of Rs 24.00 Cr and a paid-up capital of Rs 30.27 Cr.
The company currently has active open charges totaling ₹1.68 Cr.
Arun Vaghasiya, Zahurahmed Fakir, and Rakesh Vekariya serve as directors at the Company.
- CIN/LLPIN
L24230MH1981PLC025002
- Company No.
025002
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
14 Aug 1981
- Date of AGM
30 Sep 2015
- Date of Balance Sheet
31 Mar 2015
- Listing Status
Listed
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Kappac Pharma?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rakesh Vekariya  | Additional Director | 22-Dec-2014 | Current |
| Arun Vaghasiya | Additional Director | 22-Dec-2014 | Current |
| Zahurahmed Fakir | Director | 02-Jan-2015 | Current |
Financial Performance and Corporate Structure Insights of Kappac Pharma.
Kappac Pharma Ltd, for the financial year ended 2015, experienced no change in revenue, with a 0% increase. The company also saw a slight improvement in profitability, with a 5.47% increase in profit. The company's net worth dipped by a decrease of 0.21%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Kappac Pharma?
In 2015, Kappac Pharma had a public holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Indin Bank Creation Date: 30 Nov 1998 | ₹0.56 M | Open |
Indin Bank Creation Date: 30 Nov 1988 | ₹0.70 M | Open |
Indin Bank Creation Date: 09 Feb 1987 | ₹3.15 M | Open |
How Many Employees Work at Kappac Pharma?
Unlock and access historical data on people associated with Kappac Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Kappac Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Kappac Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
